483
Macleods Pharmaceuticals LimitedFDA 483 - Macleods Pharmaceuticals Limited - November 01, 2021
Record Details
An FDA inspection of Macleods Pharmaceuticals Limited, a drug product manufacturer in District Solan, India, revealed significant Good Manufacturing Practice deficiencies. Repeated observations included inadequate equipment cleaning procedures leading to drug product residue and potential cross-contamination, and deficient Out-of-Specification investigations lacking scientific rationale. Other findings involved unvalidated cleaning processes, insufficient risk assessments for impurities, failed process performance qualifications, poor computer system controls, and facility maintenance issues.
Open in Dashboard
ID · 9d34b67a-474a-41b3-b282-b8baf29864f3